Financhill
Back

Corvus Pharmaceuticals Quote, Financials, Valuation and Earnings

Corvus Pharmaceuticals Price Quote

$5.94
+0.01 (+7.03%)
(Updated: October 9, 2024 at 5:02 AM ET)

Corvus Pharmaceuticals Key Stats

Buy
58
Corvus Pharmaceuticals (CRVS) is a Buy

Day range:
$5.50 - $5.97
52-week range:
$1.05 - $6.15
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
7.25%

Volume:
341.1K
Avg. volume:
449.5K
1-year change:
298.32%
Market cap:
$371.2M
Revenue:
$0
EPS:
$-0.44

How Much Does Corvus Pharmaceuticals Make?

Data Unavailable

Is Corvus Pharmaceuticals Growing As A Company?

Data Unavailable

Corvus Pharmaceuticals Stock Price Performance

What Is Corvus Pharmaceuticals 52-Week High & Low?

Corvus Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Corvus Pharmaceuticals?

Is Corvus Pharmaceuticals Cash Flow Positive?

  • What Is CRVS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$21.2M
  • What Is Corvus Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $30.7M
  • What Is Corvus Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$2.3M

Corvus Pharmaceuticals Return On Invested Capital

Data Unavailable

Corvus Pharmaceuticals Earnings Date & Stock Price

Corvus Pharmaceuticals Competitors

Corvus Pharmaceuticals Dividend Yield

Corvus Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 39.13%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 10.13
Upside from Last Price: 70.6%

Major Shareholders

  • How many CRVS shares are owned by institutional investors?
    29.8M CRVS shares are owned by institutional investors
  • How many CRVS shares are owned by insiders?
    890.1K CRVS shares are owned by insiders